Search

everythinglearnresearchcommunity

for

Search:↓

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Gorab deficiency speeds up skin aging by disrupting protein regulation and reducing collagen.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Nicastrin deficiency may cause skin cell damage and pigmentation disorders in humans, similar to effects seen in fish.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Imatinib can cause hair loss due to lichen planopilaris.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.